Athens Medical Centre (FRA:ACS) Forward Rate of Return (Yacktman) %: 6.49% (As of Dec. 2025) — 48% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ACS Athens Medical Centre SA FRA:ACS
55 GF Score
Price €1.42
GF Value €1.81
! 9 Warning Signs
View Full Analysis

What is Athens Medical Centre Forward Rate of Return (Yacktman) %?

Athens Medical Centre FRA:ACS 55 Forward Rate of Return (Yacktman) % is 6.49% as of Dec. 2025, which is 48% below its 10-year median of 12.52. GuruFocus rates FRA:ACS with a GF Score™ of 55/100 and a GF Value™ of €1.81. The stock has 9 warning signs investors should review. Among 339 Healthcare Providers & Services companies, Athens Medical Centre ranks worse than 61.95% on this metric.

Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. Athens Medical Centre's forward rate of return for was 6.49%.

The historical rank and industry rank for Athens Medical Centre's Forward Rate of Return (Yacktman) % or its related term are showing as below:

FRA:ACS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.92   Med: 12.52   Max: 29.71
Current: 7.39

During the past 13 years, Athens Medical Centre's highest Forward Rate of Return was 29.71. The lowest was -3.92. And the median was 12.52.

FRA:ACS's Forward Rate of Return (Yacktman) % is ranked worse than
61.95% of 339 companies
in the Healthcare Providers & Services industry
Industry Median: 12.41 vs FRA:ACS: 7.39

Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Athens Medical Centre  (FRA:ACS) Forward Rate of Return (Yacktman) % Explanation

Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.


Be Aware

In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.


Athens Medical Centre Forward Rate of Return (Yacktman) % Related Terms


Athens Medical Centre Forward Rate of Return (Yacktman) % Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's Forward Rate of Return (Yacktman) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre Forward Rate of Return (Yacktman) % Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Forward Rate of Return (Yacktman) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.24 13.29 15.08 14.27 6.49

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Forward Rate of Return (Yacktman) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.08 0.00 14.27 0.00 6.49

FRA:ACS vs HCA, THC, EHC: Forward Rate of Return (Yacktman) % Comparison

For the Medical Care Facilities subindustry, Athens Medical Centre's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athens Medical Centre Forward Rate of Return (Yacktman) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's Forward Rate of Return (Yacktman) % distribution charts can be found below:

* The bar in red indicates where Athens Medical Centre's Forward Rate of Return (Yacktman) % falls into.


FRA:ACS
55GF Score
Athens Medical Centre SA FRA:ACS
Forward Rate of Return (Yacktman) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre Forward Rate of Return (Yacktman) % Calculation

Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):

If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.

The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).

Athens Medical Centre's Forward Rate of Return of Dec. 2025 is

Forward Rate of Return=Normalized Free Cash Flow/Price+5-Year EBITDA Growth Rate
=0.0645/1.74+0.0323
=6.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Rate of Return (Yacktman) % of 6.49% mean?
Athens Medical Centre (FRA:ACS) has a Forward Rate of Return (Yacktman) % of 6.49% as of Dec. 2025. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Athens Medical Centre and its competitors. This is 48% below median its historical median of 12.52. According to the industry distribution chart, Athens Medical Centre ranks #210 out of 339 companies in the Healthcare Providers & Services industry, placing it in the top 61.9%.
Is Athens Medical Centre's Forward Rate of Return (Yacktman) % too high?
Athens Medical Centre's current Forward Rate of Return (Yacktman) % of 6.49% is 48% below median its 10-year median of 12.52. The Healthcare Providers & Services industry median Forward Rate of Return (Yacktman) % is 12.41. Athens Medical Centre's value of 6.49% is 47.7% below this industry median. Based on the distribution chart, Athens Medical Centre ranks #210 out of 339 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Athens Medical Centre has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Forward Rate of Return (Yacktman) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #210 out of 339 companies for Forward Rate of Return (Yacktman) %. This places Athens Medical Centre in the lower half of its industry. The industry median Forward Rate of Return (Yacktman) % is 12.41. Athens Medical Centre's value of 6.49% is 47.7% below this benchmark. While the company's 10-year median is 12.52 vs. the industry median of 12.41, Athens Medical Centre has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Healthcare Providers & Services company?
The median Forward Rate of Return (Yacktman) % among Healthcare Providers & Services companies is 12.41, based on 339 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athens Medical Centre's current Forward Rate of Return (Yacktman) % of 6.49% is 47.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on Athens Medical Centre and its competitors. For the Healthcare Providers & Services industry, the median Forward Rate of Return (Yacktman) % is 12.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current Forward Rate of Return (Yacktman) % is 6.49%, which is 48% below median its own 10-year median of 12.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Athens Medical Centre (FRA:ACS) has a current Forward Rate of Return (Yacktman) % of 6.49%. The stock's GF Value™ is €1.81, compared to a current price of €1.42 — trading 21.5% below its estimated fair value. The current Forward Rate of Return (Yacktman) % is 6.49%, which is 48% below median its 10-year median of 12.52 and 47.7% below the Healthcare Providers & Services industry median of 12.41. Athens Medical Centre's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current Forward Rate of Return (Yacktman) % is 6.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.42 is trading 21.5% below its estimated GF Value™ of €1.81.

Key valuation signals for FRA:ACS:

  • Forward Rate of Return (Yacktman) %: 6.49% (48% below median its 10-year median of 12.52)
  • GF Value™: €1.81 vs. price of €1.42 (21.5% below fair value)
  • GF Score™: 55/100 with 9 warning signs
  • Industry Position: 47.7% below the Healthcare Providers & Services median (#210 of 339)

No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Athens Medical Centre Business Description

Other Exchanges IATR:Greece
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
55GF Score

Get the complete analysis for FRA:ACS

Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.42
Price
€1.81
GF Value